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Interactions between thymic epithelial cells (TEC) and developing thymocytes are essential
for T cell development, but molecular insights on TEC and thymus homeostasis are still
lacking. Here we identify distinct transcriptional programs of TEC that account for their age-
specific properties, including proliferation rates, engraftability and function. Further analyses
identify Myc as a regulator of fetal thymus development to support the rapid increase of
thymus size during fetal life. Enforced Myc expression in TEC induces the prolonged main-
tenance of a fetal-specific transcriptional program, which in turn extends the growth phase of
the thymus and enhances thymic output; meanwhile, inducible expression of Myc in adult
TEC similarly promotes thymic growth. Mechanistically, this Myc function is associated with
enhanced ribosomal biogenesis in TEC. Our study thus identifies age-specific transcriptional
programs in TEC, and establishes that Myc controls thymus size.
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During mouse embryogenesis, the thymus undergoes rapidgrowth, doubling in size daily until birth. After birth, thethymus continues to expand in size, although at a reduced
rate, until peaking in size at ~4 weeks of age. This maximal
thymus size is maintained in adult mice until puberty, around
8 weeks, after which it begins to decline1. As mice age, there is a
dramatic reduction in thymic cellularity, decline in thymic output
and diminished T cell function1. These dynamic changes in
thymus size through life are regulated by TEC2–4 but their
molecular basis is poorly understood.
The transcription factor Myc has been identified as controlling
organ size in Drosophila5. In vertebrates, however, a role for Myc
in controlling organ growth and size is less clear. In mice,
incremental reductions in Myc expression using an allelic series
of mouse models resulted in an incremental decrease in total
body mass, which was accompanied by hypoplasia of some tis-
sues, including the thymus6. Mice with targeted Myc depletion in
TEC present with small thymi in adulthood, accompanied by
reduced TEC proliferation rates and decreased TEC numbers7.
Hence Myc is needed in TEC for normal thymus size. However,
gain of function experiments with Myc have not been performed,
and so it is unknown if Myc activity limits thymic size and
function. In addition, it is unknown whether alterations in Myc
activity occur with age, and so might contribute to the age-
dependent pattern of vertebrate thymus growth.
Here, we use next generation sequencing techniques to contrast
transcriptional dynamics between fetal and adult TEC. We
determine genes underlying the transcriptional programs that
differ between fetal and adult TEC, and identify Myc and
downstream Myc target genes as controllers of the rapid expan-
sion in thymus size from embryonic stages until young adult-
hood. We show that ectopic Myc restores the expression of a
Myc-controlled gene module to adult TEC, together with func-
tional properties that are normally specific to embryonic TEC.
Our results provide insight into mechanisms that underlie func-
tional differences between fetal and adult TEC. They establish
that Myc activity in TEC restricts thymus size through life and
provide a clear demonstration that Myc activity controls organ
size in vertebrates.
Results
Transcriptional diversity of TEC through development. To
identify age-specific transcriptional profiles of TEC, we per-
formed RNA-seq on isolated TEC populations from selected
developmental timepoints. TEC comprise cortical TEC (cTEC),
and medullary TEC (mTEC)8. At E13.5, cTEC, and mTEC sub-
sets cannot be distinguished based on the markers Ly51 and UEA,
therefore we isolated total TEC. We isolated cTEC and mTEC
from E15.5, E17.5, newborn, adult and aged mice (Gating stra-
tegies in Supplementary Fig. 1a and b). Experimental replicates
clustered closely, as expected (Supplementary Fig. 1c).
Principal-component analysis (PCA) revealed that PC1 (20%
of all variance) separated samples based on lineage (Fig. 1a).
Thus, cTEC and mTEC maintain distinct transcriptional
identities, regardless of developmental timepoint. PC2 (10%
of all variance) separated samples by developmental timepoint.
This second component revealed greater transcriptional
changes at 2-day increments of cTEC development during
embryogenesis to adulthood, compared with changes seen
between the 17-month+ age increase between adult and aged
cTEC. We found several thousand genes had significantly
altered expression between E13.5 TEC and adult cTEC or
mTEC (Supplementary Fig. 1d). Moreover, over a thousand
genes upregulated or downregulated with age were shared
between the two lineages. In contrast, many fewer genes
demonstrated significantly altered expression between adult
and aged cTEC and mTEC (Supplementary Fig. 1e), of which
most were lineage-specific, with less than a hundred upregu-
lated and downregulated genes overlapping between cTEC and
mTEC.
We determined biological processes associated with the age-
dependent diversification of TEC, using gene set variation
analysis (GSVA)9 performed separately on cTEC and mTEC
compared against the same E13.5 TEC subset (Supplementary
Fig. 1f). The 2000 most differentially expressed genes across all
timepoints (Supplementary Data 1) were selected for this
analysis10. Significantly altered pathways are listed in Supple-
mentary Data 2. Genes highly expressed in both fetal cTEC and
mTEC were enriched for pathways involved in cell cycle,
ribosomal biogenesis and other described Myc target genes
(Fig. 1b, c). Genes continuing to decline in expression between
adult and aged cTEC remained enriched for many of these
pathways (Supplementary Fig. 1g and Supplementary Data 3). In
contrast, pathways enriched in adulthood or upregulated with age
included lysosomes and antigen presentation in both cTEC and
mTEC (Fig. 1b, c). These data considerably extend previous work
demonstrating that cell cycle signatures are enriched in fetal TEC,
and antigen processing and presentation pathways are highly
enriched in adult TEC11,12.
We focused on genes that govern pathways highly enriched at
the earliest stages in TEC development, which included cell cycle,
ribosomal biogenesis, and other genes downstream of Myc, with
the presumption that these control the rapid expansion in thymic
size observed in early life.
Increased proliferation and ribosomal biogenesis in fetal TEC.
To examine how transcriptional alterations to cell cycle genes in
TEC during thymic maturation correlated with decreased rates of
cell division, we performed in vivo single pulse bromodeoxyur-
idine (BrdU) labeling and measured the frequency of BrdU
incorporating TEC 18 h+ after labeling13. At E15.5, ~30% of TEC
were BrdU+, this declined to under 20% in TEC at birth, and
decreased to <5% by 6 weeks of age (Fig. 2a).
GSVA identified overrepresentation of ribosomal genes at
embryonic stages in TEC development (Fig. 1b, c). Genes
involved in ribosomal biogenesis (KEGG Ribosome) displayed
diminishing expression with age in cTEC and mTEC from the
high levels observed in the E13.5 TEC and E15.5 cTEC and
mTEC (Fig. 2b).
Approximately 85% of RNA in a cell is ribosomal (r)RNA14;
thus, measuring total RNA abundance is a simple estimate of
cellular ribosome content. To examine if the age-dependent
decrease in ribosomal protein gene transcripts correlates with a
decline in ribosomal concentration, we measured the total RNA
abundance of TEC across this data set using Pyronin Y (PY) that
intercalates into RNA. Co-staining for intracellular PY and DAPI
permitted the exclusion of proliferating DAPI+ TEC from the
analysis, as proliferating cells typically contain higher levels of
RNA and TEC proliferation rates vary with age (Fig. 2a).
Assessment of PY fluorescence on E17.5, newborn, and adult
samples demonstrated age-dependent reduction in total RNA
abundance in non-cycling TEC over these developmental time-
points (Fig. 2c).
Single-cell transcriptome analysis of fetal and adult TEC. To
assess in greater depth the age-dependent transcriptional diversity
in TEC, we transcriptionally profiled TEC from different ages
using single-cell RNA-seq (scRNA-seq). We focused on cTEC as
TEC progenitors have been reported to express cTEC markers
prior to differentiating into their downstream cTEC/mTEC
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progeny in the fetal thymus15 and we wanted to include such
putative TEC progenitors which might control embryonic thymic
expansion. Visualization of data using a t-distributed stochastic
neighbor embedding (t-SNE) plot identified clusters of TEC as
well as contaminating non-TEC (Supplementary Fig. 2a and b).
Newborn and adult cTEC contained a T cell contaminated cluster
(cluster 10, Supplementary Fig. 2c) likely representing thymic
nurse cells, consisting of CD4+ CD8+ thymocytes enclosed
within cTEC16. Adult mTEC clustered separately from adult
cTEC, and lacked detectable expression of cTEC specific genes
including Psbmb11 (Supplementary Fig. 2d)17, confirming the
purity of the limited number of adult cTEC. In addition, we
identified a small subset of described putative TEC progenitors in
postnatal mice expressing Plet1, Cldn3, and Cldn4 genes (cluster
13)18,19. Contaminating clusters (10, 11, and 12) and adult mTEC
were removed before further analysis and all used populations are
displayed in the t-SNE plot in Fig. 3a.
Myc activity declines in TEC during development. Cell cycle
genes can dominate transcriptional variation within cell popula-
tions20. Therefore, some, if not all distinct gene signatures iden-
tified by the bulk RNA-seq in embryonic TEC could conceivably
result from high proliferation rates of TEC at early developmental
timepoints. We therefore used the scRNA-seq data set to examine
if the observed decline of ribosomal protein transcripts during
development occurred within non-proliferating cTEC.
We determined the proliferation status of individual cells in
each sample by constructing a proliferation score using the Seurat
CellCycleScoring function21 from a combined list of G2M-phase
and S-phase genes20 (Fig. 3b). The frequency of cells with a high
proliferation score declined from E13.5 to newborn and further in
adult, consistent with the declining frequency of BrdU+ cTEC
with age observed in Fig. 2a. Next, we generated a ribosomal score
from the KEGG Ribosome gene set. We observed a dramatic
decrease in the ribosomal score between E13.5 and newborn
subsets (Fig. 3c); and a further but smaller decline between
newborn and adult cTEC, consistent with gene expression profiles
at the population level (Fig. 2b). The cTEC were then divided into
subsets with low or high proliferation scores (Fig. 3d). Both
subsets displayed an equivalent reduction in ribosomal score
between E13.5 and newborn, thus indicating that the observed
decline in expression of genes implicated in ribosomal biogenesis
with age is not a trivial consequence of reduced numbers of
cycling cells but is independent of cell cycle status. We
additionally tested the strength of the relationship between
ribosomal expression and age by fitting a general linear model to
the data. Ribosomal score and developmental timepoint were
strongly correlated (R2= 0.67), and remained strongly correlated
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Fig. 1 Transcriptional diversity of TEC through development. Total TEC (CD45−EpCAM+) from embryonic day 13.5 (E13.5, black circles), or cTEC
(CD45−EpCAM+Ly51+UEA−) (red circles) and mTEC (CD45−EpCAM+Ly51−UEA+) (blue circles) from mice at the indicated ages (E15.5, E17.5, newborn
(NB), adult or aged were cell sorted for bulk RNA-seq analysis. a Two-dimensional representation of populations via a principle component analysis, where
each data point is an individual sample and the shaded ovals identify replicate populations. b, c A row normalized heatmap of expression of gene pathways
highly enriched in embryonic or adult cTEC (b) or mTEC (c) samples at indicated age, identified by gene set variation analysis.
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To confirm the decline in expression of ribosomal genes with
increased age was not driven by cellular heterogeneity, such as
frequencies of undifferentiated cells, we repeated this analysis
using clusters defined by transcriptional similarity (Supplemen-
tary Fig. 2b). Interestingly, the proliferation score for the cluster
analysis displayed dramatic differences between individual
clusters at E15.5 and NB stages (Supplementary Fig. 2e), revealing
heterogeneity in cTEC based on proliferation status at these
developmental stages (genes differentially expressed between
clusters of the same developmental timepoint are listed in
Supplementary Data 4). However, cTEC clusters at each
developmental timepoint had similar ribosomal scores, that
declined with developmental age (Supplementary Fig. 2f). This
cluster analysis strengthens the finding that the decline in
expression of ribosomal genes during development is indepen-
dent of cell cycle. We conclude that this decline in expression of
ribosomal genes with age is a key feature of the development of
thymic epithelial cells.
Transcription factor Myc is a critical controller of ribosomal
biogenesis22. We, therefore, examined if Myc protein abundance
differed in TEC through development. We used a green
fluorescent protein (GFP)-c-Myc knock-in mouse, where GFP
is a surrogate for Myc protein. Myc-GFP protein levels were
highest in TEC at E13.5 and declined in expression until birth
(Fig. 3e) in both cTEC and mTEC. Myc-GFP was not detectable
above background in adult TEC of either lineage (Fig. 3f).
Interestingly, transcript levels of Myc by bulk RNA-seq analysis







































































































































































































Fig. 2 TEC have reduced rates of proliferation and ribosomal biogenesis with age. a Representative flow plots of the frequency of BrdU+ cells in cTEC
(CD45−EpCAM+Ly51+UEA−) (above) and mTEC (CD45−EpCAM+Ly51−UEA+) (below) displayed as histograms (black line) overlaid on the negative
control (gray bar). Bar graphs represent the frequencies of BrdU+ cTEC and mTEC populations. b A row normalized heatmap of expression of KEGG
ribosomal genes at indicated ages, where each column represents an average of a minimum of three biological replicates. c Representative flow plot of
Pyronin Y staining on DAPI−CD45−EpCAM+ total TEC from indicated timepoints, overlaid as a histogram, where gray filled histogram is RNAse treated
adult cells. Bar graph represents the MFI of Pyronin Y at each indicated timepoint, relative to the Pyronin Y MFI of the adult sample which is set to 1 and so
has no error bar. All bar graphs show mean ± SEM for a minimum n= 3 mice per age. A two-tailed unpaired Student’s t test was performed to determine
significance. *p < 0.05, **p < 0.01, ****p < 0.0001. The source data underlying (a, c), are provided as a Source Data file.
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in Myc mRNA and protein expression suggests Myc is post-
transcriptionally regulated in adult TEC23. The results establish
that a reduction in Myc protein levels occurs through fetal
development, concordant with the earlier observed age-related
reduction in expression of Myc target genes in TEC.
Transgenic expression of Myc in TEC drives thymic growth. To
examine if the decrease in Myc protein observed in TEC after
birth limits thymic growth in adult mice, we ectopically expressed
Myc in TEC and examined the effects of continual Myc expres-
sion on thymic size. We crossed FoxN1Cre recombinase mice24
to mice with a human MYC cDNA transgene inserted into the
Rosa-26 locus (R26StopFLMyc)25. We called these FoxN1MycTg
mice. Population level RNA-seq confirmed increased human
MYC mRNA in cTEC, and to a lesser degree in mTEC, in adult
FoxN1MycTg mice (Supplementary Fig. 3a). Furthermore, we
confirmed an increase in Myc protein by flow cytometry in adult
FoxN1MycTg cTEC and mTEC (Supplementary Fig. 3b).
Next, we explored the biological consequences of forced Myc
expression in TEC on thymic size. Transgenic expression of Myc in
TEC conferred a dramatic increase in thymic size in adult mice
(Fig. 4a, b). Whereas transgenic Myc had no effect on thymic size
at E14.5 or at the newborn stages in development, by 4 weeks of
age mice displayed a twofold increase in thymic size compared
with littermate controls (Fig. 4a). The size of the thymus continued
to expand into adulthood, causing mice to die from 15 weeks
onward2. This undetectable increase in size until after birth is













































































































































Fig. 3 A decline in Myc activity and protein levels in TEC during fetal development. Single-cell RNA-seq analysis of cell sorted total TEC (CD45−EpCAM+)
from embryonic day 13.5 (E13.5, purple) and cTEC (CD45−EpCAM+Ly51+UEA−) from embryonic day 15.5 (E15.5, pink), newborn (NB, blue) and adult
(green) mice. a A t-SNE plot of TEC populations, colored and clustered by indicated ages; each dot is a cell. b A violin plot of the proliferation score applied
to cells at each indicated timepoint. The red line separates cells with a high proliferation score above the line and a low proliferation score below the line;
percentages of cells above the line are indicated in red. Violins plots of the ribosomal score applied to total cells (c), or cells with a high proliferation
and low proliferation score (d) at indicated timepoints. e Myc-GFP levels displayed as histogram gated on CD45-EpCAM+ total TEC from E13.5, or cTEC
(CD45−EpCAM+Ly51+UEA−) (above) and mTEC (CD45−EpCAM+Ly51−UEA+) (below) subsets from homozygote GFP-c-Myc knock-in mice at each
indicated age, overlaid on litter mate WT GFP-c-Myc knock-in controls (filled gray histograms). f Bar graph represents the relative Myc-GFP MFI against
WT aged matched controls in total CD45−EpCAM+ total TEC at each indicated timepoint. Bar graphs show mean ± SEM for a minimum n= 3 mice per
age. A two-tailed unpaired Student’s t test was performed to determine significance. *p < 0.05, **p < 0.01, ***p < 0.001. The source data underlying (f) are
provided as a Source Data file.
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Fig. 4 Transgenic expression of Myc in TEC drives thymic growth. a Total thymus counts of WT (white bars) or FoxN1MycTg (gray bars) mice at
embryonic day 14.5 (E14.5), newborn (NB) or 4 weeks of age. b Photographs of 10-week-old thymi from WT (left) or FoxN1MycTg (right) mice.
c Representative flow plots of the frequency of CD45− EpCAM+ total TEC (above), or Ly51+ UEA− cTEC and Ly51− UEA+ mTEC pre-gated on CD45−
EpCAM+ total TEC (below), from 4-week-old WT or FoxN1MycTg mice. Bar graphs display the frequency (above) or cell number (below) of total TEC
(left), cTEC (middle) or mTEC (right) of adult WT or FoxN1MycTg mice. d Representative flow plots of CD80+ ClassII+ mTEChi or CD80−ClassIIlow
mTEClow, pre-gated on Ly51− UEA+ mTEC, or histograms displaying the frequency of Aire+ and Aire− cells pre-gated on CD80+ ClassII+ mTEChi from
WT or FoxN1MycTg mice. Bar graphs display the frequency (above) or numbers (below) of the corresponding populations. All bar graphs show mean ±
SEM for a minimum n= 3 mice per genotype. A two-tailed unpaired Student’s t test was performed to determine significance. *p < 0.05, **p < 0.01, ****p <
0.0001. The source data underlying (a), (c), (d) are provided as a Source Data file.
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endogenous Myc already supports high Myc activity during fetal
development, and so ectopically expressed Myc has little effect
until endogenous Myc has diminished. The frequency and number
of EpCAM+ TEC were greatly increased in the thymus of adult
FoxN1MycTg mice (Fig. 4c). The ratio of cTEC to mTEC was also
altered, with an increased frequency of cTEC recovered from adult
FoxN1MycTg thymi; however, the numbers of both TEC lineages
were significantly increased in the FoxN1MycTg, due to the
dramatic increase in number of TEC (Fig. 4c). FoxN1MycTg mice
possessed normal frequencies of CD80+Class II+mTEChi and
CD80−Class IIlowmTEClow subsets, and unaffected frequencies of
Aire+mTEChi (Fig. 4d); again, the numbers of all mTEC subsets
were significantly increased in FoxN1MycTg thymi, due to the
increase in total numbers. Although the overall size of thymic lobes
was considerably larger in FoxN1MycTg mice, thymic architecture
remained relatively unchanged, with no obvious defects observed
by H&E staining (Supplementary Fig. 4a).
Transgenic Myc expression in TEC increases thymic function.
The expansion of TEC numbers in FoxN1MycTg mice fostered a
dramatic increase in the number of thymocytes recovered from
adult thymi. Proportions of the major thymocyte populations
were minimally altered in the enlarged thymi, based on CD4,
CD8, and TCRβ expression, whilst numbers of each population
were increased (Supplementary Fig. 4b and c). More detailed
analysis detected some differences within the FoxN1MycTg single
positive (SP) CD4 and SP CD8 thymocyte compartments.
FoxN1MycTg thymi had a small but consistent increase in fre-
quency of FoxP3+ CD25+ T regulatory cells compared with WT
controls (Supplementary Fig. 4d). Furthermore, an increase in the
frequency of the most mature CD69−CD62L+ SP4 and SP8
thymocytes was detected within the FoxN1MycTg adult thymus
(Supplementary Fig. 4e). However, this was not a consequence of
increased proliferation rate (Supplementary Fig. 4f).
The expansion in the TEC compartment increased the number
of T cells in the periphery of adult FoxN1MycTg mice26. The
cellularity of the spleen was unchanged in adult FoxN1MycTg
mice, and the frequency and number of extrathymically generated
B cells was not significantly altered (Supplementary Fig. 5a).
However, increased frequencies and numbers of T cells were
measured in the spleen (Supplementary Fig. 5b) due to a
significant increase in the number of naive T cells (Supplemen-
tary Fig. 5c and d). The numbers of central memory and effector
memory CD4 T cells were unaltered in the spleen of the
FoxN1MycTg mice (Supplementary Fig. 5c). The numbers of
central memory, but not effector memory, CD8 T cells were
increased (Supplementary Fig. 5d). In addition, the frequencies of
T Regulatory cells were significantly reduced within the periphery
of the FoxN1MycTg mice, although the overall increase in the
numbers of total CD4 T cells resulted in no alterations to the
numbers of this subset (Supplementary Fig. 5e).
The elevated numbers of naive T cells suggested an increase in
recent thymic emigrants. We crossed the FoxN1MycTg mice to
Rag2-GFP reporter mice, where retained GFP expression marks
recent thymic emigrants27 and confirmed FoxN1MycTgRag2-
GFP mice had increased frequencies of Rag2-GFP+ T cells
(Supplementary Fig. 5f).
Collectively, the results confirm transgenic expression of Myc
in TEC resulted in increased thymus size in adult mice, which
consequently increased T cell output.
Transcriptional effects of transgenic Myc expression. To
establish if the Myc induced TEC expansion and thymic growth
in adult FoxN1MycTg mice was mediated by similar mechanisms
to those driving thymic growth in the fetal thymus, we examined
the transcriptional effects of enforced Myc expression on TEC.
We first determined the changes between adult FoxN1MycTg
cTEC and mTEC and WT controls using bulk RNA-seq. This
comparison revealed thousands of genes significantly upregulated
and downregulated in the FoxN1MycTg TEC compared with WT
(Supplementary Fig. 6a), with overlap between the two TEC
lineages. Genes upregulated in the FoxN1MycTg cTEC and
mTEC were associated with ribosomal biogenesis and translation;
whereas genes declining in expression were implicated in antigen
processing and presentation, cell adhesion, interferon gamma
response, and response to cytokine (Supplementary Fig. 6b and
Supplementary Data 5). Interestingly, many of the pathways
upregulated in FoxN1MycTg cTEC and mTEC correspond with
pathways enriched in WT TEC with age shown in Fig. 1b, c, most
strikingly pathways involving the ribosome.
Next, we transcriptionally profiled adult WT and FoxN1MycTg
cTEC and mTEC, plus E17.5 cTEC, by scRNA-seq (Fig. 5a and
Supplementary Fig. 6c). We removed contaminants (clusters 11
and 14, Supplementary Fig. 6c and d). FoxN1MycTg cTEC and
mTEC clustered close to their WT counterparts and did not
express fetal-specific genes such as Hmga2 (Supplementary Fig. 6c
and d). FoxN1MycTg cTEC separated into two clusters (clusters 3
and 8, Supplementary Fig. 6c), one clustered with the WT cTEC,
whilst the other clustered independently. Genes differently
expressed between these two clusters are listed in Supplementary
Data 6. FoxN1MycTg cTEC and mTEC displayed an increased
ribosomal score compared with adult WT cTEC and mTEC
(Fig. 5c). The proliferation score was also increased in the
FoxN1MycTg cTEC and mTEC compared with adult WT
(Fig. 5b).
Collectively, these results suggest the transcriptional effects of
the Myc transgene in TEC results in a dramatic increase in
ribosomal biogenesis and a more modest rise in rates of
proliferation. Thus, the transcriptional consequences of forced
Myc expression in adult FoxN1MycTg mice closely mimicked
those transcriptional patterns that indicated high Myc activity in
early life in TEC.
Nonetheless, adult FoxN1MycTg cTEC did not cluster with the
E17.5 cTEC, because some fetal genes were not rescued by
transgenic Myc expression, indicating that transgenic Myc
represented only one component of the fetal transcriptional
program as it only conferred expression of a limited set of fetal
enriched genes. We generated a list of fetal genes that were highly
expressed in WT fetal samples, and not upregulated or only
minimally upregulated in adult FoxN1MycTg cTEC (Supple-
mentary Fig. 7a). This list was used to generate a fetal score and
applied to the scRNA-seq data set in Fig. 5 (Supplementary
Fig. 7b). This assessment confirmed that these index genes are not
highly expressed in any adult WT cTEC or mTEC and are not
upregulated in FoxN1MycTg TEC. We speculate this gene list
contains upstream Myc controllers.
We explored the transcriptional changes of TEC isolated from
another large thymic mouse model. RNA sequencing of mTEC
from adult Keratin 5 promoter-driven cyclin D1-transgenic
(K5CyclinD1) mice4 confirmed an increase in expression of cell
cycle genes (Supplementary Fig. 7c)28, but interestingly, without
an increase in expression of ribosomal genes (Supplementary
Fig. 7d). Thus, Myc induced thymic growth is distinct from
growth resulting from forced expression of the Cyclin D1 cell
cycle controller.
Transgenic Myc expression in TEC does not alter mTEC sub-
sets. We next examined the effects of the Myc transgene on TEC
diversity and heterogeneity. As cTEC subsets are not well
described, we focused the analysis on the four major mTEC
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Fig. 5 Transgenic Myc confers expression of a limited set of fetal-specific genes in adult TEC. scRNA-seq analysis performed on cTEC (CD45−EpCAM+
Ly51+UEA−) or mTEC (CD45−EpCAM+Ly51−UEA+) isolated from adult WT or FoxN1MycTg mice, and a cTEC sample from embryonic day 17.5 (E17.5
cTEC). a A t-SNE representation of the populations, colored and clustered by original identity. b A violin plot of the proliferation score for the indicated
populations. The red line separates cells based on their proliferation score, high score above the line and low score below the line, percentages of cells above
the line are indicated in red. c A violin plot of the ribosomal score applied to the indicated populations. d, e A t-SNE representation, regressed out for cell
cycle, of WT and FoxN1MycTg mTEC populations, colored and clustered by original identity (d) or gene expression similarity (e). f The fraction of four
(of the five) mTEC clusters identified in (e), for WT mTEC (above) or FoxN1MycTg mTEC (below) samples. The colors of the bars correspond to colors
allocated to the four clusters in the t-SNE plot displayed in (e). g A violin plot of the Aire-dependent gene score of either the WT or FoxN1MycTg cells that
make up each of the four indicated mTEC subsets.
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subsets, that have been newly defined by scRNA-seq11, and
examined if FoxN1MycTg mTEC had altered sub-population
structure (Fig. 5d). We performed cluster analysis on cell cycle
regressed data, to reduce differences driven by altered prolifera-
tion rates between WT and FoxN1MycTg, at a resolution that
enabled the identification of the four mTEC subsets (Fig. 5e),
based on expression of selected marker genes (Supplementary
Fig. 8a)11. All four mTEC clusters contained both WT and
FoxN1MycTg cells (Fig. 5d, f), in addition to a small unidentified
cluster (mTECV, Fig. 5e) that we did not further consider at this
time. The most highly differentiated genes per cluster are in
Supplementary Data 7. The proportions of mTEC subsets were
relatively unchanged between the WT and FoxN1MycTg (Fig. 5f),
except for an increase in mTEC IV thymic tuft cells in the
FoxN1MycTg sample. The most highly differentiated genes in the
WT versus FoxN1MycTg cells per cluster are listed in Supple-
mentary Data 8. The preserved frequency of Aire-expressing cells
was complementary to flow cytometric data (Fig. 4d). All
FoxN1MycTg cells in the four mTEC clusters had an increased
ribosomal score compared with the WT cells of that cluster
(Supplementary Fig. 8c) and an increased proliferation score in
three of the mTEC clusters (Supplementary Fig. 8b). We addi-
tionally examined the expression of known Aire-dependent genes
in each cluster, for the WT or FoxN1MycTg samples (Fig. 5g)11.
All clusters displayed comparable levels of expression of Aire-
dependent genes.
Myc expression increases the frequency of proliferating TEC.
To determine whether ectopic Myc expression increased rates of
proliferation, we performed in vivo single pulse BrdU labeling.
This identified a twofold increase in the frequency of BrdU+
proliferating adult FoxN1MycTg TEC (Fig. 6a). As an control,
CD45+ thymocytes in the same samples did not display an
increased rate of proliferation. This result confirmed that condi-
tional ectopic Myc expression forced increased rates of pro-
liferation in adult TEC.
Myc expression increases numbers of active ribosomes. To
confirm the Myc transgene increased ribosomes in adult TEC, we
measured total RNA abundance in the FoxN1MycTg TEC. The
FoxN1MycTg TEC had increased PY MFI compared with con-
trols (Fig. 6b), and thus, higher total RNA abundance per cell.
Moreover, we assessed alterations to the amount of active protein
synthesis in adult TEC with ectopic Myc expression using ribo-
puromycylation (RPM)29. We detected significantly more RPM
staining in adult FoxN1MycTg TEC (Fig. 6c), and therefore an
increased number of actively translating ribosomes.
These results demonstrated that transgenic expression of Myc
in TEC resulted in increased rates of ribosomal biogenesis and
proliferation in the adult thymus that in turn promoted thymic
growth. This confirms that cell proliferation and ribosomal
biogenesis are downstream targets of Myc in TEC. The high
abundance of Myc protein in fetal TEC, in addition to the high
rates of cell proliferation and ribosomal biogenesis at this
developmental timepoint, indicates Myc is a regulator of the
transcriptional diversity between fetal and adult TEC, that
supports the rapid expansion of thymic size during
embryogenesis.
Myc expression in adult TEC confers fetal properties. The
engraftment potential of TEC following intrathymic transfer is
lost by one month of age30. We, therefore, assessed if ectopic Myc
expression in adult TEC conferred transplantability. TEC enri-
ched thymic samples were prepared from adult FoxN1MycTg or
WT controls and intrathymically injected into sub-lethally
irradiated WT recipients (Fig. 7a). The percentage of EpCAM+
TEC recovered from hosts receiving FoxN1MycTg donor cells
was higher than hosts receiving WT donor cells (Fig. 7b). The
thymus counts from hosts receiving FoxN1MycTg donor cells


























































































Fig. 6 Myc expression increases the frequency of proliferating TEC and the
number of actively translating ribosomes. a Representative histograms and
bar graphs of the frequency of BrdU+ CD45− EpCAM+ total TEC (above)
or BrdU+ CD45+ EpCAM− total thymocytes (below) in adult WT or
FoxN1MycTg mice. Gray lines on histograms represent the negative control.
b A histogram of pyronin Y staining on CD45−EpCAM+ total TEC
populations from WT adult (black line) or FoxN1MycTg adults (red line),
overlaid against an adult WT sample treated with RNAse (gray line). Bar
graph represents pyronin Y MFI relative to the adult WT control, which is
set to 1 in all experiments and so has no error bar. c A histogram of
puromycin antibody staining on CD45− EpCAM+ total TEC from adult WT
(black) or FoxN1MycTg (red) mice treated with either puromycin (PMY)
plus cxcycloheximide (CHX) staining (solid lines) or puromycin plus
harringtonine (HNT) (dotted lines). Bar graph represents the MFI of
puromycin (PMY) gated on total TEC from WT adult or FoxN1MycTg
adults, calculated from the MFI of PMY+ CHX treated mice, from which
we subtracted the MFI from PMY+HNT treated mice to eliminate the
signal associated with stalled ribosomes. All bar graphs show mean ± SEM
for a minimum of n= 3 mice per genotype. A two-tailed unpaired Student’s
t test was performed to determine significance. **p < 0.01, ***p < 0.001. The
source data underlying figures are provided as a Source Data file.
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TEC per thymus (Fig. 7c). Hence, continued transgenic expres-
sion of Myc into adulthood in TEC preserves their engraftment
ability. Moreover, transplantation of adult FoxN1MycTg TEC
into WT adult thymi drives thymic growth.
Myc expression in adult TEC drives thymic regeneration. We
next assessed if re-expressing Myc in adult TEC was sufficient to
stimulate thymic growth, even after the fetal program had been
extinguished. We generated an inducible MycTg mouse model, by
crossing the floxed MycTg mouse to a K5-CreERT2Cre mouse31,
named here iMycTg. Administration of tamoxifen activates the
ERT2-Cre controlled by Keratin5 locus control elements and
results in the expression of the Myc transgene. Keratin 5 is
expressed in TEC progenitor subsets and mTEC, therefore, this
model facilitated restricted expression of the Myc transgene in
TEC after tamoxifen administration26.
After 5 days of tamoxifen treatment, adult K5+MycTg+ and
K5−MycTg+ mice were left for an additional 60 days+ before
sacrificing and determining TEC and thymic cell counts (Fig. 7d).
The percentage of EpCAM+ TEC recovered from tamoxifen
treated iMycTg mice was tenfold higher than WT controls
(Fig. 7e), similar to the percentages recovered from the
FoxN1MycTg mice (Fig. 4c). Furthermore, the thymus counts
were significantly increased in iMycTg mice, with a fourfold rise
in cell numbers (Fig. 7f). This resulted in a highly significant
expansion of TEC numbers in the iMycTg thymi. Therefore, the
Myc transgene does not need to be continually expressed from
fetal stages in development to drive thymic growth, but instead,
re-expression of Myc in adult TEC is sufficient to promote thymic
growth and regeneration.
Discussion
Thymic epithelial cells are essential in generating a functional,
diverse and self-tolerant T cell repertoire8. Here, we used popu-
lation and single-cell RNA-seq to identify distinct transcriptional
programs of TEC at fetal and adult stages. We discovered
increased expression of gene targets of Myc at fetal stages in
development, including genes controlling ribosomal biogenesis
and the cell cycle. We found a stepwise decline in expression of
these genes through fetal development, that was concordant with
declining expression of Myc protein. By conditionally enhancing
Myc protein expression in TEC we demonstrated that Myc
conferred expression of a limited fetal transcriptional program,
that included genes involved in cell cycle progression and ribo-
somal biogenesis; and enhanced thymic growth from early
adulthood without jeopardizing thymic function. Moreover,
enforced Myc expression preserved the fetal-specific engraftment
potential of TEC into adulthood, and drove thymic growth in the
adult or aging thymus. These results establish that a decline in
Myc activity from fetal through adult life controls the rate of
thymus growth and limits overall thymus size. Collectively, our
findings establish two distinct age-related TEC transcriptional
programs: rapid growth at early developmental times leading to
maintenance of a functioning thymus in adulthood.
While Myc is known to control organ size in Drosophila5 its
contribution in vertebrates was previously unclear. Here, we



























































































































Fig. 7 Transgenic Myc expression in adult TEC confers fetal properties and can drive thymic regeneration. a Schematic of the experimental design of
intrathymic injections. b Representative flow plots of the frequency of CD45−EpCAM+ total TEC recovered from WT hosts receiving adult WT or
FoxN1MycTg donor TEC. c Bar graphs display total cells in thymus (left) and CD45−EpCAM+ total TEC counts (right) from WT host thymi receiving WT
(white) or FoxN1MycTg (gray) donor TEC. Bar graphs show mean ± SEM, where circles display experiment 1 and squares display experiment 2. d A
schematic of the experimental design of tamoxifen induced Myc expression in TEC. e Representative flow plots of the frequency of CD45−EpCAM+ total
TEC recovered from K5−MycTg+ (WT) or K5+MycTg+ (iMycTg) tamoxifen treated mice. f Bar graphs display total thymus counts or CD45−EpCAM+
total TEC counts from K5−MycTg+ (white) or K5+MycTg+ (gray stripe) tamoxifen treated mice. Bar graphs show mean ± SEM for a minimum n= 2 mice
per genotype. A two-tailed unpaired Student’s t test was performed to determine significance. *p < 0.05, **p < 0.01, ****p < 0.0001. The source data
underlying (c, f) are provided as a Source Data file.
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growth in mice. How Myc mediates its role in different cellular
processes has been intensely studied, because dysregulation of
Myc activity is connected to the development of a large range of
human cancers32,33. Myc has been hypothesized to be a universal
amplifier of all active genes, offering an explanation as to how it is
involved in so many biological processes34. In our study, TEC-
specific transgenic expression of Myc allowed the identification of
genes whose relative expression increased in response to
increased Myc activity in TEC. These included genes involved in
cell cycle, and more strikingly, ribosomal biogenesis, which is
rate-limiting for cell growth and replication35. We confirmed that
ectopic expression of Myc increased the number of actively
translating ribosomes, together with the abundance of total RNA
in TEC, and elevated the fraction of proliferating TEC. Further-
more, K5CyclinD1 TEC transcriptional profiling confirmed that
increased cell cycle was not sufficient to cause an increase in
expression of ribosomal protein genes2, indicating that the
changes we saw were not merely consequences of increased rates
of cell cycle in fetal TEC.
Although the major focus of this transcriptome analysis was on
changes that occur between fetal stages to young adulthood,
further declines in Myc activity were evident from adult to aged
cTEC. Thus, the dramatic reduction in Myc activity we observed
during fetal development continues to occur at more modest rates
from adulthood to aging, and we speculate this underlies the
reduction in thymic size during involution. It follows that
manipulations that upregulate Myc activity could prevent or
reverse thymic involution and perhaps enhance thymus regen-
eration. This conclusion is further strengthened by our observa-
tion that intrathymic transplantation of adult FoxN1MycTg TEC
can promote thymic growth, and that inducing Myc expression in
the adult or aged thymus can also support dramatic increases in
thymic size. Hence, physiological regulators of Myc are candi-
dates for therapeutic interventions to improve thymic function.
Transcriptional profiling identified many genes with high levels
of expression in fetal TEC that are not upregulated in adult
FoxN1MycTg TEC, indicating they are not downstream of Myc.
This list of fetal-specific genes may control fetal-specific TEC
properties critical for thymic function that are independent of
Myc. Such genes, together with Myc and its many targets, con-
stitute a fetal transcriptional program that underlies the exclusive
properties of fetal TEC. In addition, they offer a starting point to
identify upstream controllers of Myc. This gene list includes Igf2,
Igf2bp3, and Igf2bp1. Igf family members have known roles in
controlling Myc expression36, and the RNA-binding proteins
Igf2bp1 and Igf2bp3 bind Myc mRNA37,38. Igf2bp1 promotes
Myc stability by preventing its mRNA degradation via its asso-
ciation with a sequence in the Myc open reading frame, termed
the coding region determinant (CRD)37. Igf2bp1/2/3 enhance
mRNA translation via recognition of m6A in mRNA39, and Myc
is established to possess m6A in mouse HSCs40, suggesting a
mechanism by which Igf2bp RNA-binding proteins might control
Myc mRNA stability and translation.
Although postnatal TEC expressed Myc mRNA, they lacked
Myc protein. This discrepancy between Myc protein and Myc
transcripts levels indicates that Myc is post-transcriptionally and/
or post-translationally regulated in postnatal TEC. Myc mRNA
stability is controlled by different mechanisms41. Multiple miR-
NAs target Myc42,43. In addition, post-translational modifications
control Myc activity and function44. Interestingly, and distinct
from non-transgenic adult TEC, FoxN1MycTg adult TEC clearly
expressed Myc protein and exhibited increased Myc activity. The
FoxN1MycTg mouse has a human MYC cDNA that lacks the 5′
and 3′ UTR as well as introns25; these may be the targets of post-
transcriptional control in adult TEC. In addition, human and
mouse Myc are 89% conserved at the amino acid level (NCBI
Protein database), and some of the differing amino acids may be
the site of post-translational modifications that affect protein
stability.
In summary, our findings reveal dramatic transcriptional dif-
ferences between TEC from the embryonic and adult thymus,
providing mechanistic insight into transcriptional and functional
differences between fetal and adult TEC. By clearly demonstrating
that Myc controls thymic growth and size, we establish Myc as a
possible therapeutic target in modulating thymic function and
regeneration.
Methods
Mice. B6 (CD45.2) and B6-Ly5.1 (CD45.1) mice were purchased from Jackson
Laboratory. The MycTg mice25, in which a loxP-flanked ‘stop’ cassette precedes a
human MYC cDNA inserted into the Rosa-26 locus, were purchased from Jackson
Laboratory (Stock No: 020458) and crossed with FoxN1Cre mice that were a gift
from G.Hollander24. Myc-GFP mice45, with Myc fused to GFP in the N-terminus,
were purchased from Jackson Laboratory (Stock No: 21935).
Krt5-CreERT2 knock-in mice31 were purchased from Jackson Laboratory
(Stock No: 029155). Rag2-EGFP mice46 were purchased from Jackson Laboratory
(Stock No: 005688). Mice described as newborn were 0–2 days in age and of either
sex. Mice described as adult for flow cytometry/sequencing experiments were
4–6 weeks of age and of either sex (unless otherwise stated). Aged mice were
between 18 and 21 months of age. The ages of embryonic mice are specified with
E0.5 being noon of the day of the discovered plug. Animal procedures were
approved by relevant National Institutes of Health Animal Care and Use
Committees.
Tissue preparation. Thymus and spleen were dissected into RPMI (ThermoFisher
Scientific) containing 5% newborn calf serum (NCS) (Atlanta Biologicals) and
mechanically teased with forceps to prepare a single-cell suspension. Splenocytes
were treated with ACK Lysing Buffer (Lonza) for 3 min on ice to eliminate red
blood cells. When analyzing newborn and adult thymic epithelial cells, single-cell
thymic suspensions were enzymatically digested with Liberase TM (63 μg/ml;
Roche) and DNase I (20 μg/ml; Roche) for 40 min shaking at 37 °C. Following
digestion, epithelial cells were enriched by centrifugation in a Percoll gradient.
Briefly, cells were resuspended in 4 ml of 1.115 g ml−1 isotonic Percoll (GE
Healthcare Life Science) and overlaid with 2 ml of 1.065 g/mL isotonic Percoll,
followed by a layer of 2 ml of PBS. Samples were then centrifuged at 2700 RPM at
4 °C for 30 min with the brakes off. The TEC enriched samples were taken from the
interface between the Percoll and PBS layer. Embryonic thymi were disaggregated
in 0.25% trypsin/0.02% EDTA (Sigma) solution at 37 °C for 7–10 min, with a
single-cell suspension made by gentle repetitive pipetting. Embryonic thymi were
not subject to an enrichment step. All cell suspensions were then further processed
and stained as described below.
Flow cytometry. Thymocytes and splenocytes were stained and analyzed in FACS
buffer (PBS containing 0.1% sodium azide, 1 mM EDTA, and 0.5% BSA). Thymic
epithelial cell preps were analyzed in MACS buffer (PBS containing 2 mM EDTA
and 0.5% FCS). Antibodies specific for CD45.2 (104), CD45.1(A20) CD4 (GK1.5),
CD8-α (53-6.72), TCR-β (H57), B220 (RA3-6B2), CD19 (1D3), Ly51 (6C3),
EpCAM (G8.8), CD80 (16-10A1), MHC Class II (M5/114.15.2), CD44 (IM7),
CD62L (MEL-14), CD25 (PC61.5), CD69 (H1.2F3), and Streptavidin PECy7 were
from eBioscience. Biotinylated UEA-1 (B-1065) was from Vector Labs. LIVE/
DEAD discrimination was performed by staining with DAPI (Sigma). All analyses
were presented on singlet live cells. For intracellular staining of Myc protein and
Aire, cells were first stained for cell surface molecules, permeabilized using the
eBioscience’s transcription factor staining buffer set (cat: 00-5523-00) according to
the manufacturer’s instructions and then either stained for c-Myc rabbit mono-
clonal antibody (Cell Signaling; D84C12), followed by Goat anti Rabbit Alexa
Fluor® 488 secondary (Invitrogen; A11008); or Aire (5H12). Samples were acquired
using a flow cytometer (LSRFortessa; BD) and analyzed using FlowJo software
(Tree Star). TEC were sorted using an Aria flow cytometer (BD). All cell sort
purities were >98%. Absolute cell numbers were obtained using an Accuri C6 PLUS
flow cytometer (BD). All newborn and adult TEC numbers were calculated from
the frequency of CD45- EpCAM+ cells of pre-enrichment samples.
BrdU staining. Mice were injected intraperitoneally (i.p) with BrdU (1.5 mg)
18–20 h prior to sacrifice, and thymi processed as stated above. Cell suspensions
were intracellular stained for BrdU using the BD bioscience APC BrdU flow kit
(552598), according to the manufacturer’s instructions. Control mice received
vehicle alone injections.
Pyronin Y staining. All cell suspensions of adult and embryonic thymi were
fixed and permeabilized using eBioscience’s transcription factor staining buffer
set according to the manufacturer’s instructions and first stained with DAPI
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(25 mg/ml), followed by Pyronin Y (Sigma P9172-1G) (1 μg/ml). Control cells were
treated with RNAse A (Millipore 70856) at 10 mg/ml at 37 °C for 1 h.
Puromycin staining. The antibiotic puromycin (PMY) is an aminoacyl-tRNA
analog that binds to the ribosome A-site and is covalently incorporated onto the 3′
end of the nascent polypeptide resulting in chain termination. After fixation and
permeabilization, the puromycylated polypeptides can be detected by an intracel-
lular stain with an antibody specific to puromycin. Treatment with cxcyclohex-
imide (CHX) prior to PMY stabilizes the ribosome-nascent chain complex and
prevents puromycylated polypeptide release. As puromycin can also incorporate
into stalled ribosomes, i.e, ribosomes that are not actively translating the bound
mRNA, control mice were treated with harringtonine (HNT) prior to PMY. HNT
inhibits translation initiation, while allowing currently elongating ribosomes to
finish translation of the bound mRNA. The intracellular RPM signal from CHX
and PMY treated mice minus the RPM signal after HNT and PMY treatment
generates a measure of the number of active ribosomes29. Mice were injected
intravenously with 100 μl of harringtonine solution (HNT) (1 mg/ml, Santa Cruz
Biotechnology) or cycloheximide solution (CHX) (3.4 mg/ml, Enzo Life Sciences)
for 15 min before intravenous injection with 100 μl of puromycin (PMY)
(10 mg/ml, Calbiochem) in PBS (Life Technologies) that was warmed to 37 °C.
Mice were sacrificed 10 min post PMY injection and thymi processed as stated
above. Samples were stained with LIVE/DEAD® Fixable Blue Dead Cell Stain Kit
(ThermoFisher Scientific) on ice for 10 min, then fixed and permeabilized in
fixation/permeabilization buffer (1% paraformaldehyde, ThermoFisher Scientific;
0.0075% digitonin, Wako) in PBS for 20 min at 4 °C. Cells were then labeled with a
directly conjugated (using Life Technologies protein labeling kit as per the man-
ufacturer’s instructions) anti-PMY Ab (clone PMY-2A4) for 1 h.
H&E staining. Thymi were harvested from adult FoxN1MycTg mice, fixed in 4%
paraformaldehyde (ThermoFisher Scientific), and mounted in paraffin. Five- to
eight-micrometer sections were cut and stained with H&E (performed by an NIH
core facility). The central sections were imaged using a Leica MZ125 microscope
and a Nikon Coolpix 5000 camera.
Bulk RNA sequencing. A minimum of three replicates of cTEC and mTEC subsets
from each age point were isolated by cell sorting from B6 WT mice according to
the gating strategy shown in Supplementary Fig. 1a. Three additional cTEC and
mTEC samples were isolated from FoxN1MycTg adult mice. FoxN1MycTg adult
samples were 10 weeks of age. We did not use Spike-in controls because a standard
methodology is not available for their use with small cell numbers (2000 or more
cells in these experiments). Replicates were isolated from individual mice in two or
more independent experiments (independent cell isolation, RNA extraction, library
preparation, and RNA sequencing). RNA was extracted using the RNeasy plus
micro kit (Qiagen) according to the manufacturer’s instructions. Quality control
was performed by Bioanalyzer (Agilent), and RNA samples with an RNA integrity
number > 9 were subsequently used. mRNA sequencing libraries were prepared
using the SMARTer Ultra Low Input RNA kit v3 (Clontech) and Nextera XT DNA
library preparation kit (Illumina). Paired-end sequence reads of 126 bp were
generated by a HiSeq2500 sequencer (Illumina). The raw RNA-seq FASTQ reads
were aligned to the mouse genome (mm10) using STAR (v. 2.5.2b47) on two-pass
mode with mouse Gencode (release 15) gene transfer format. Genes were subse-
quently counted using Rsubread48 and because we found T cell marker genes in
adult cTEC samples specifically, we used k-means clustering to find a gene cluster
which was enriched for known T cell markers (Cd247, Rag1, Cd3e, Cd3g, Cd3d,
Cd4, Cd28) using the pheatmap package (Kolde 2018). A full list of the 292T cell
contaminant genes is provided in Supplementary Data 9. These genes were
removed from all samples prior to analysis for gene expression changes (Aged vs
Adult, Fetal vs Adult, and WT vs FoxN1MycTg) using limma-voom with quantile
normalization PCA plots were generated using prcomp function from stats pack-
age. Venn diagrams show intersection of gene lists derived using twofold change
and p < 0.05. Pathway enrichment analyses for the Adult vs Aged (Supplementary
Fig. 1e) and WT vs FoxN1MycTg (Supplementary Fig. 6b) comparisons were
subsequently performed using the top 1000 genes (sorted by t-statistic) in each
direction using the Reactome, Molecular Signature Database (MSigDB49,50):
Hallmark, C2, GO, and KEGG pathways, using the Fisher’s exact test (https://
github.com/CCBR/l2p).
Differentially expressed genes across cTEC (Fig. 1b) and across mTEC groups
(Fig. 1c) were determined using the limma package10, each set including the 13.5
TEC timepoint as the baseline. The top 2000 genes were subjected to Gene Set
Variation Analysis (GSVA9) to calculate individual gene set enrichment scores
using the MSigDB C2:curated and H:hallmark and C5:GO Gene Ontology
databases. Visualization was performed using R (R Development CoreTeam51). To
confirm consistency between biological replicates, we performed unsupervised
hierarchical clustering using a minimum spanning tree. All data presented in heat
maps are counts per million (CPM), normalized and log2 transformed. Human
MYC counts were quantified by running STAR aligning to the human genome
(hg38) using Gencode v.25 gtf. K5CyclinD1 and WT mTEC populations were
isolated and sequenced according to methods stated in Ohigashi et al.28.
Single-cell RNA sequencing. TEC populations were isolated by cell sorting from
B6 WT or FoxN1MycTg mice according to the gating strategy shown in Supple-
mentary Fig. 1a and b. We used the droplet-based GemCode Chromium tech-
nology to capture the two separate data sets. Data set one in Fig. 3: E13.5 total TEC
(1981) E15.5 cTEC (3571) newborn cTEC (3605), adult cTEC (507), adult mTEC
(1586), each expressing a median of 1764–2839 genes per sample. Data set two in
Fig. 5: E17.5 cTEC (8381 cells) adult cTEC (514 cells), adult mTEC (5428 cells)
adult FoxN1MycTg cTEC (4670 cells), adult FoxN1MycTg mTEC (6736 cells),
expressing medians of 2500–3200 genes per sample and all captured at the same
time. scRNA-seq libraries were prepared using the Chromium Single Cell 3′ kits,
according to the manufacturer’s instructions (v2 chemistry, 10x Genomics). The
obtained libraries were sequenced with a NextSeq (v2 chemistry, Illumina). Pri-
mary analysis was performed with the Cellranger v2.0.1 software using the default
parameters. Median number of UMI counts ranged between 3990 and 10,176 per
cell. Cells with extremely low number of UMI counts were filtered out using the
default settings in Cell Ranger. Single-cell analysis was performed using Seurat
(v.2.3.4) (Butler et al.52) applying default settings unless otherwise stated. Cells with
>5% mitochondrial gene content and >5000 genes per cell were removed. Variables
selected to be regressed out were nUMI and percent mitochondrial content. The
irlba implementation PCA53, was run and the first 20 principal components were
used in subsequent analysis. Cells were clustered using Seurat’s FindClusters
function. To visualize the data, t-distributed stochastic neighbor embedding (t-
SNE) plots were generated using the Seurat’s RunTSNE function. All t-SNE plots
displayed are on data not regressed for cell cycle, with the exception of Fig. 5d, e.
Contaminants were identified based on signature gene expression and clusters were
removed from the analysis (clusters 10, 11, and 12 from Supplementary Fig. 2c and
clusters 11 and 14 from Supplementary Fig. 6d). Such cells formed their own
clusters and appeared distant from the main progenitor populations on t-SNE.
Contaminant cells were electronically removed prior to subsequent analysis.
Seurat’s FindClusters function was used to cluster the remaining data using default
perplexity. Differentially expressed genes between clusters were identified using
Seurat’s FindMarkers function with default settings: only genes showing expression
in at least 10% of cells in one of the groups compared were considered; p-values
were determined using the Wilcoxon ranked sum test; and genes having a
Bonferonni-adjusted p-value of >0.05 were discarded. A generalized linear model54
was used to determine significance. Violin plots shown in figures were made using
Seurat’s normalized data. Additional analysis and visualization were done using
R51. The adult WT and FoxN1MycTg scRNA data set was visualized using the
same analytical tools.
Generation of gene scores. We used the Seurat CellCycleScoring function to
create scores for Ribosome using genes from the Kegg Ribosome gene set, or scores
for Proliferation using a combined list of G2M and S-phase genes using a pre-
viously published marker set20. Fetal-specific genes were extracted using Find-
Markers function comparing E13.5 cells against NB cells that had low proliferation
scores. This initial list was filtered to remove genes for ribosomal proteins and
remaining cell cycle genes, and further filtered to remove genes upregulated more
than twofold in adult FoxN1MycTg cTEC population compared with adult WT
cTEC in the bulk RNA-seq data. The fetal gene list was then used to similarly create
a score using the Seurat CellCycleScoring function. Myc pathways were taken from
MSigDB49,55), namely DANG_MYC_TARGETS_UP and DANG_MYC_TAR-
GETS_DOWN56, Myc Max Targets57.
Intrathymic transplantation. TEC enriched thymus samples from adult CD45.2+
WT and FoxN1MycTg mice were prepared as described above. The frequency of
CD45− EpCAM+ TEC sample was determined by flow cytometry prior to
injection. WT TEC numbers injected were 166,000 (experiment 1) and 200,000
(experiment 2) per mouse. FoxN1MycTg TEC numbers injected were 133,000
(experiment 1) and 200,000 (experiment 2) per mouse. Both experiments gave
similar results and so data were pooled. Cells were kept at 4 °C prior to injection.
Intrathymic injections were performed as previously described58 into CD45.1+
WT hosts, 6–10 weeks in age, that had received 500 Rad irradiation 2 h prior
to surgery. Mice were anesthetized by intraperitoneal injection of Ketamine
(100 mg/ml stock) (VetOne) plus Xylazine (20 mg/ml stock) (Akorn Animal
Health) and provided with Buprenorphine (PAR Pharmaceutical) 0.5–2.0 mg/kg
subcutaneous pre and postoperatively. Ten microliters of cells in suspension were
injected into one thymic lobe using a Hamilton syringe equipped with a 30-gauge
needle (Fisher Scientific). One or three wound clips (Fisher Scientific) were applied
to close the incision. Mice were sacrificed 7–10 weeks post injection and successful
injections were determined by the presence of CD45.2+ donor cells in the host
CD45.1+ thymus. Successful engraftment was measured as an increase in total
thymic cellularity and TEC number. Total counts and TEC samples were then
stained for flow cytometric analysis as described above.
Tamoxifen treatment. Tamoxifen (Letco Medical) was dissolved in corn oil
(Sigma C8267-500ml) at a concentration of 20 mg/ml by shaking 6 h at 37 °C.
Adult mice were administered with 100 μl tamoxifen (2 mg per mouse) via intra-
peritoneal injection daily, for 5 consecutive days. Mice were sacrificed 25 weeks+
post treatment.
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Statistics. Statistical significance was performed with GraphPad Prism. Differ-
ences between groups of mice were determined by a two-tailed unpaired Student’s
t test. If the F test to compare variance had a p value < 0.05 an unpaired t test with
Welch’s correction was performed, where we do not assume equal standard
deviation.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All bulk RNA-seq data and scRNA-seq data is accessible GSE131368. The source data
underlying Figs. 2a, c, 3f, 4a, c, d, 6a, b, c, 7c and f and Supplementary Figs. 4c, d, e, 5a, b,
c, d, e and f are provided as a Source Data file.
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